Differential effects of insufflated, subcutaneous, and intravenous growth hormone on bone growth, cognitive function, and NMDA receptor subunit expression

Endocrinology

Volumn 151, Issue 9, 2010, Pages 4418-4427

  Park, Sung Won ^a   Shin, Sooyoung ^c   Kim, Chi Hwa ^b   Ko, Ah Ra ^b   Kwak, Min Jung ^f   Nam, Mi Hyun ^b   Park, So Young ^b   Kim, Su Jin ^e   Sohn, Young Bae ^a   Galinsky, Raymond E ^c   Kim, Hojoong ^a   Yeo, Yoon ^c,d   Jin, Dong Kyu ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c PURDUE UNIVERSITY   (United States)

^d PURDUE UNIVERSITY   (United States)

^e National Cancer Center   (South Korea)

^f Good Gang An Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NR1 NMDA RECEPTOR; NR2A NMDA RECEPTOR; NR2B NMDA RECEPTOR; POWDER;

ANIMAL; AREA UNDER THE CURVE; BONE DEVELOPMENT; CHEMISTRY; COGNITION; DRUG EFFECTS; ELECTRON MICROSCOPY; ESCAPE BEHAVIOR; GENE EXPRESSION; GENETICS; HIPPOCAMPUS; HUMAN; HYPOPHYSECTOMY; INTRAVENOUS DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; MALE; MAZE TEST; MEMORY; METABOLISM; PHYSIOLOGY; POWDER; RANDOMIZATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; AREA UNDER CURVE; BONE DEVELOPMENT; COGNITION; ESCAPE REACTION; GENE EXPRESSION; GROWTH HORMONE; HIPPOCAMPUS; HUMANS; HYPOPHYSECTOMY; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MALE; MAZE LEARNING; MEMORY; MICROSCOPY, ELECTRON; POWDERS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77956048708     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0152     Document Type: Article

References (31)

1. Darzy KH, Shalet SM 2005 Hypopituitarism as a consequence of brain tumours and radiotherapy. Pituitary 8:203-211
2. Leschek EW, Rose SR, Yanovski JA, Troendle JF, Quigley CA, Chipman JJ, Crowe BJ, Ross JL, Cassorla FG, Blum WF, Cutler Jr GB, Baron J 2004 Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 89:3140-3148 (Pubitemid 38960690)
3. Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, Gill A, Chaussain JL, Frisch H, Yturriaga R, Attanasio AF 2005 Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. J Pediatr 146:45-53
4. Storer TW, Woodhouse LJ, Sattler F, Singh AB, Schroeder ET, Beck K, Padero M, Mac P, Yarasheski KE, Geurts P, Willemsen A, Harms MK, Bhasin S 2005 A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment. J Clin Endocrinol Metab 90:4474-4482
5. Le Grevès M, Steensland P, Le Grevès P, Nyberg F 2002 Growth hormone induces age-dependent alteration in the expression of hippocampal growth hormone receptor and N-methyl-D-aspartate receptor subunits gene transcripts in male rats. Proc Natl Acad Sci USA 99:7119-7123
6. Le Grevès M, Zhou Q, Berg M, Le Grevès P, Fholenhag K, Meyerson B, Nyberg F 2006 Growth hormone replacement in hypophysectomized rats affects spatial performance and hippocampal levels of NMDA receptor subunit and PSD-95 gene transcript levels. Exp Brain Res 173:267-273
7. Li F, Tsien JZ 2009 Memory and the NMDA receptors. N Engl J Med 361:302-303
8. Stolar MW, Baumann G 1986 Secretory patterns of growth hormone during basal periods in man. Metabolism 35:883-888 (Pubitemid 16025555)
9. Shah N, Aloi J, Evans WS, Veldhuis JD 1999 Time mode of growth hormone (GH) entry into the bloodstream and steady-state plasma GH concentrations, rather than sex, estradiol, or menstrual cycle stage, primarily determine the GH elimination rate in healthy young women and men. J Clin Endocrinol Metab 84:2862-2869
10. Coste J, Letrait M, Carel JC, Tresca JP, Chatelain P, Rochiccioli P, Chaussain JL, Job JC 1997 Long-term results of growth hormone treatment in France in children of short stature: population, register based study. BMJ 315:708-713
11. Patton JS 1996 Mechanisms of macromolecule absorption by the lungs. Adv Drug Deliv Rev 19:3-36
12. Schanker LS 1978 Drug absorption from the lung. Biochem pharmacol 27:381-385
13. Patton JS, Fishburn CS, Weers JG 2004 The lungs as a portal of entry for systemic drug delivery. Proc Am Thorac Soc 1:338-344
14. Cryan SA, Sivadas N, Garcia-Contreras L 2007 In vivo animal models for drug delivery across the lung mucosal barrier. Adv Drug Deliv Rev 59:1133-1151
15. Tronde A, Nordén B, Marchner H, Wendel AK, Lennernäs H, Bengtsson UH 2003 Pulmonary absorption rate and bioavailability of drugs in vivo in rats: structure-absorption relationships and physicochemical profiling of inhaled drugs. J Pharm Sci 92:1216-1233
16. Patton JS, Byron PR 2007 Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov 6:67-74
17. White S, Bennett DB, Cheu S, Conley PW, Guzek DB, Gray S, Howard J, Malcolmson R, Parker JM, Roberts P, Sadrzadeh N, Schumacher JD, Seshadri S, Sluggett GW, Stevenson CL, Harper NJ 2005 EXUBERA: pharmaceutical development of a novel product for pulmonary delivery of insulin. Diabetes Technol Ther 7:896-906
18. Pearson J 2006 Inhalation technologies - a breath of fresh air. Drug Delivery Report Spring/Summer:19-21
19. Brunton S 2008 Insulin delivery systems: reducing barriers to insulin therapy and advancing diabetes mellitus treatment. Am J Med 121:S35-S41 (Pubitemid 351726337)
20. Walvoord EC, de la Peña A, Park S, Silverman B, Cuttler L, Rose SR, Cutler G, Drop S, Chipman JJ 2009 Inhaled growth hormone (GH) compared with subcutaneous GH in children with GH deficiency: pharmacokinetics, pharmacodynamics, and safety. J Clin Endocrinol Metab 94:2052-2059
21. Vanbever R, Mintzes JD, Wang J, Nice J, Chen D, Batycky R, Langer R, Edwards DA 1999 Formulation and physical characterization of large porous particles for inhalation. Pharm Res 16:1735-1742
22. Thompson DM, Winsauer PJ, Mastropaolo J 1987 Effects of phencyclidine, ketamine and MDMA on complex operant behavior in monkeys. Pharmacol Biochem Behav 26:401-405
23. Frederick DL, Gillam MP, Allen RR, Paule MG 1995 Acute behavioral effects of phencyclidine on rhesus monkey performance in an operant test battery. Pharmacol Biochem Behav 52:789-797
24. Ichinose M, Tojo K, Nakayama M, Hasegawa T, Kawaguchi Y, Sakai O 1995 Boucher-Neuhauser syndrome associated with hypocalciuric hypercalcemia. Intern Med 34:18-23
25. Chen HI, Yeh DY, Liou HL, Kao SJ 2006 Insulin attenuates endotoxin-induced acute lung injury in conscious rats. Crit Care Med 34:758-764 (Pubitemid 43308267)
26. Kao SJ, Wang D, Yeh DY, Hsu K, Hsu YH, Chen HI 2004 Static inflation attenuates ischemia/reperfusion injury in an isolated rat lung in situ. Chest 126:552-558
27. Ben-Jebria A, Chen D, Eskew ML, Vanbever R, Langer R, Edwards DA 1999 Large porous particles for sustained protection from carbachol-induced bronchoconstriction in guinea pigs. Pharm Res 16:555-561
28. Bosquillon C, Lombry C, Préat V, Vanbever R 2001 Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. J Control Release 70:329-339
29. Edwards DA, Hanes J, Caponetti G, Hrkach J, Ben-Jebria A, Eskew ML, Mintzes J, Deaver D, Lotan N, Langer R 1997 Large porous particles for pulmonary drug delivery. Science 276:1868-1871 (Pubitemid 27443665)
30. Bal HS, Ghoshal NG 1988 Morphology of the terminal bronchiolar region of common laboratory mammals. Lab Anim 22:76-82
31. 2009 The United States Pharmacopeia: The National Formulary (USP32/NF27). Rockville, MD: The United States Pharmacopeial Convention